308 related articles for article (PubMed ID: 25586014)
1. Systematic review of prognostic factors for mortality in dogs with immune-mediated hemolytic anemia.
Swann JW; Skelly BJ
J Vet Intern Med; 2015 Jan; 29(1):7-13. PubMed ID: 25586014
[TBL] [Abstract][Full Text] [Related]
2. Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs.
Piek CJ; Junius G; Dekker A; Schrauwen E; Slappendel RJ; Teske E
J Vet Intern Med; 2008; 22(2):366-73. PubMed ID: 18346140
[TBL] [Abstract][Full Text] [Related]
3. Immune-mediated hemolytic anemia: 70 cases (1988-1996).
Reimer ME; Troy GC; Warnick LD
J Am Anim Hosp Assoc; 1999; 35(5):384-91. PubMed ID: 10493413
[TBL] [Abstract][Full Text] [Related]
4. Immunosuppressive therapy for canine immune-mediated hemolytic anemia.
Al-Ghazlat S
Compend Contin Educ Vet; 2009 Jan; 31(1):33-41, 44; quiz 44. PubMed ID: 19241356
[TBL] [Abstract][Full Text] [Related]
5. Urinary 11-dehydrothromboxane B
Conway EA; Evans NP; Ridyard AE
J Vet Intern Med; 2022 Jan; 36(1):86-96. PubMed ID: 34859495
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of different prognostic markers in dogs with primary immune-mediated hemolytic anemia].
Griebsch C; Arndt G; Kohn B
Berl Munch Tierarztl Wochenschr; 2010; 123(3-4):160-8. PubMed ID: 20329649
[TBL] [Abstract][Full Text] [Related]
7. Case-control study of plasma mean platelet component concentration and survival analysis for dogs with immune-mediated hemolytic anemia.
Zoia A; Gerou-Ferriani M; Drigo M; Caldin M
J Am Vet Med Assoc; 2018 Jun; 252(11):1384-1392. PubMed ID: 29772969
[TBL] [Abstract][Full Text] [Related]
8. [Use of human intravenous immunoglobulin in dogs with primary immune mediated hemolytic anemia].
Gerber B; Steger A; Hässig M; Glaus TM
Schweiz Arch Tierheilkd; 2002 Apr; 144(4):180-5. PubMed ID: 12038216
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002).
Weinkle TK; Center SA; Randolph JF; Warner KL; Barr SC; Erb HN
J Am Vet Med Assoc; 2005 Jun; 226(11):1869-80. PubMed ID: 15934255
[TBL] [Abstract][Full Text] [Related]
10. Neutrophil Extracellular Traps in Plasma from Dogs with Immune-mediated Hemolytic Anemia.
Lawson C; Smith SA; O'Brien M; McMichael M
J Vet Intern Med; 2018 Jan; 32(1):128-134. PubMed ID: 29214674
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of immunosuppressive regimens for immune-mediated haemolytic anaemia: a retrospective study of 42 dogs.
Swann JW; Skelly BJ
J Small Anim Pract; 2011 Jul; 52(7):353-8. PubMed ID: 21668886
[TBL] [Abstract][Full Text] [Related]
12. Use of enoxaparin in dogs with primary immune-mediated hemolytic anemia: 21 cases.
Panek CM; Nakamura RK; Bianco D
J Vet Emerg Crit Care (San Antonio); 2015; 25(2):273-7. PubMed ID: 25773906
[TBL] [Abstract][Full Text] [Related]
13. Splenectomy in the management of primary immune-mediated hemolytic anemia and primary immune-mediated thrombocytopenia in dogs.
Bestwick JP; Skelly BJ; Swann JW; Glanemann B; Bexfield N; Gkoka Z; Walker DJ; Silvestrini P; Adamantos S; Seth M; Warland J
J Vet Intern Med; 2022 Jul; 36(4):1267-1280. PubMed ID: 35801263
[TBL] [Abstract][Full Text] [Related]
14. Use of serum concentrations of interleukin-18 and monocyte chemoattractant protein-1 as prognostic indicators in primary immune-mediated hemolytic anemia in dogs.
Kjelgaard-Hansen M; Goggs R; Wiinberg B; Chan DL
J Vet Intern Med; 2011; 25(1):76-82. PubMed ID: 21092010
[TBL] [Abstract][Full Text] [Related]
15. ACVIM consensus statement on the treatment of immune-mediated hemolytic anemia in dogs.
Swann JW; Garden OA; Fellman CL; Glanemann B; Goggs R; LeVine DN; Mackin AJ; Whitley NT
J Vet Intern Med; 2019 May; 33(3):1141-1172. PubMed ID: 30847984
[TBL] [Abstract][Full Text] [Related]
16. Serum Thymidine Kinase 1, Canine-C-Reactive Protein, Haptoglobin, and Vitamin D Concentrations in Dogs with Immune-Mediated Hemolytic Anemia, Thrombocytopenia, and Polyarthropathy.
Grobman M; Outi H; Rindt H; Reinero C
J Vet Intern Med; 2017 Sep; 31(5):1430-1440. PubMed ID: 28804921
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein concentration in dogs with primary immune-mediated hemolytic anemia.
Griebsch C; Arndt G; Raila J; Schweigert FJ; Kohn B
Vet Clin Pathol; 2009 Dec; 38(4):421-5. PubMed ID: 19392754
[TBL] [Abstract][Full Text] [Related]
18. Potentially antigenic RBC membrane proteins in dogs with primary immune-mediated hemolytic anemia.
Tan E; Bienzle D; Shewen P; Kruth S; Wood D
Vet Clin Pathol; 2012 Mar; 41(1):45-55. PubMed ID: 22315967
[TBL] [Abstract][Full Text] [Related]
19. Immune-mediated haemolytic anaemia in 110 dogs in Victoria, Australia.
McAlees TJ
Aust Vet J; 2010 Jan; 88(1-2):25-8. PubMed ID: 20148823
[TBL] [Abstract][Full Text] [Related]
20. Predicting Outcome in dogs with Primary Immune-Mediated Hemolytic Anemia: Results of a Multicenter Case Registry.
Goggs R; Dennis SG; Di Bella A; Humm KR; McLauchlan G; Mooney C; Ridyard A; Tappin S; Walker D; Warman S; Whitley NT; Brodbelt DC; Chan DL
J Vet Intern Med; 2015; 29(6):1603-10. PubMed ID: 26473338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
